Hyliion Holdings Corp

HYLN is in a Stage 4 decline with confirmed lower highs and lower lows, trading below the declining 9-day, 20-day, and 50-day moving averages. Active continuation patterns and sustained overhead supply reinforce a bearish medium-term outlook. Short-term timing is unfavorable as price is rejecting at the 9-day EMA and failing to stabilize, and the Speculative strategy demands clear rejection at EMAs for selling—which is now evident. Therefore, immediate sell-side engagement is warranted.

• ↑$41.7M U.S. Navy contract with potential $50M funding in 2026
• ↑Q2 revenue of $4.94M (+225% YoY) beat estimates by $2.54M
• ↓Q2 net loss of $13.9M highlights deepening unprofitability